Skip to main content
Top
Published in: Inflammation 5/2012

01-10-2012

Beneficial Effect of the Polysaccharides from Bupleurum smithii var. parvifolium on “Two-Hit” Acute Lung Injury in Rats

Authors: Xiao-Qin Cheng, Lu-Jin Song, Hong Li, Hongye Di, Yun-Yi Zhang, Dao-Feng Chen

Published in: Inflammation | Issue 5/2012

Login to get access

ABSTRACT

Radix Bupleuri is a traditional Chinese herb frequently used in the prescriptions for the treatment of inflammatory diseases. This study was to determine whether the crude polysaccharides isolated from the roots of Bupleurum smithii var. parvifolium (BPs) had beneficial effects on a “two-hit” acute lung injury model in rats. A two-hit lung injury model characterized by hemorrhagic shock followed by reperfusion and intratracheal lipopolysaccharide (1 mg kg−1) administration was established in Wistar rats. Drugs and saline were administered 30 min after the start of resuscitation. The two-hit acute lung injury model was successfully established. After oral administration, all BPs groups ameliorated pathological injury with lessened complement C3c deposit in lung. BPs 10 and 20 mg kg−1 diminished the ratio of wet-to-dry weight. In bronchoalveolar lavage (BAL) fluids, the protein concentration, the leukocytes counts, and the lung myeloperoxidase were significantly reduced. BPs also mediated the decreases in interleukin-6 and tumor necrosis factor-α in BAL fluids and in sera. Furthermore, BPs 20 mg kg−1 decreased the total complement hemolytic activity. BPs had beneficial effects on two-hit acute lung injury. The mechanisms of BPs on inflammatory disease might relate to its inhibitory effect on increased production of proinflammatory mediators and on overactivation of complement.
Literature
1.
go back to reference Chu, C.H., D.D. Liu, Y.H. Hsu, K.C. Lee, and H.I. Chen. 2007. Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats. Pulmonary Pharmacology and Therapeutics 20: 503–512.PubMedCrossRef Chu, C.H., D.D. Liu, Y.H. Hsu, K.C. Lee, and H.I. Chen. 2007. Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats. Pulmonary Pharmacology and Therapeutics 20: 503–512.PubMedCrossRef
2.
go back to reference Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.PubMedCrossRef Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.PubMedCrossRef
3.
go back to reference Yeh, C.C., C.C. Lin, S.D. Wang, Y.S. Chen, B.H. Su, and S.T. Kao. 2006. Protective and anti-inflammatory effect of a traditional Chinese medicine Xia-Bai-San, by modulating lung local cytokine in a murine model of acute lung injury. International Immunopharmacology 6: 1506–1514.PubMedCrossRef Yeh, C.C., C.C. Lin, S.D. Wang, Y.S. Chen, B.H. Su, and S.T. Kao. 2006. Protective and anti-inflammatory effect of a traditional Chinese medicine Xia-Bai-San, by modulating lung local cytokine in a murine model of acute lung injury. International Immunopharmacology 6: 1506–1514.PubMedCrossRef
4.
go back to reference Jacob, H.S., P.R. Craddock, D.E. Hammerschmidt, and C.F. Moldow. 1980. Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. New England Journal of Medicine 302: 789–794.PubMedCrossRef Jacob, H.S., P.R. Craddock, D.E. Hammerschmidt, and C.F. Moldow. 1980. Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. New England Journal of Medicine 302: 789–794.PubMedCrossRef
5.
go back to reference Hammerschmidt, D.E., L.J. Weaver, L.D. Hudson, P.R. Craddock, and H.S. Jacob. 1980. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Lancet 1: 947–949.PubMedCrossRef Hammerschmidt, D.E., L.J. Weaver, L.D. Hudson, P.R. Craddock, and H.S. Jacob. 1980. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Lancet 1: 947–949.PubMedCrossRef
6.
go back to reference Weigelt, J.A., D.E. Chenoweth, K.R. Borman, and J.F. Norcross. 1988. Complement and the severity of pulmonary failure. The Journal of Trauma 28: 1013–1019.PubMedCrossRef Weigelt, J.A., D.E. Chenoweth, K.R. Borman, and J.F. Norcross. 1988. Complement and the severity of pulmonary failure. The Journal of Trauma 28: 1013–1019.PubMedCrossRef
7.
go back to reference Hutchison, J. 2000. Neutrophils in sepsis, septic shock, and adult respiratory distress syndrome: how stiff is too stiff? Critical Care Medicine 28: 2659–2660.PubMedCrossRef Hutchison, J. 2000. Neutrophils in sepsis, septic shock, and adult respiratory distress syndrome: how stiff is too stiff? Critical Care Medicine 28: 2659–2660.PubMedCrossRef
8.
go back to reference Zhao, R.Z., S.J. Liu, S.R. Mao, and Y.J. Wang. 2009. Study on liver targeting effect of vinegar-baked Radix Bupleuri on resveratrol in mice. Journal of Ethnopharmacology 126: 415–420.PubMedCrossRef Zhao, R.Z., S.J. Liu, S.R. Mao, and Y.J. Wang. 2009. Study on liver targeting effect of vinegar-baked Radix Bupleuri on resveratrol in mice. Journal of Ethnopharmacology 126: 415–420.PubMedCrossRef
9.
go back to reference Ikegami, F., M. Sumino, Y. Fujii, T. Akiba, and T. Satoh. 2006. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Human & Experimental Toxicology 25: 481–494.CrossRef Ikegami, F., M. Sumino, Y. Fujii, T. Akiba, and T. Satoh. 2006. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Human & Experimental Toxicology 25: 481–494.CrossRef
10.
go back to reference Wang, Z., H. Li, H. Xu, X.L. Yue, X.Q. Cheng, W.J. Hou, Y.Y. Zhang, and D.F. Chen. 2009. Beneficial effect of Bupleurum polysaccharides on autoimmune disease induced by Campylobacter jejuni in BALB/c mice. Journal of Ethnopharmacology 124: 481–487.PubMedCrossRef Wang, Z., H. Li, H. Xu, X.L. Yue, X.Q. Cheng, W.J. Hou, Y.Y. Zhang, and D.F. Chen. 2009. Beneficial effect of Bupleurum polysaccharides on autoimmune disease induced by Campylobacter jejuni in BALB/c mice. Journal of Ethnopharmacology 124: 481–487.PubMedCrossRef
11.
go back to reference Cheng, X.Q., H. Li, X.L. Yue, J.Y. Xie, Y.Y. Zhang, H.Y. Di, and D.F. Chen. 2010. Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifolium. Journal of Ethnopharmacology 130: 363–368.PubMedCrossRef Cheng, X.Q., H. Li, X.L. Yue, J.Y. Xie, Y.Y. Zhang, H.Y. Di, and D.F. Chen. 2010. Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifolium. Journal of Ethnopharmacology 130: 363–368.PubMedCrossRef
12.
go back to reference Xu, H., Y.Y. Zhang, J.W. Zhang, and D.F. Chen. 2007. Isolation and characterization of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii. International Immunopharmacology 7: 175–182.PubMedCrossRef Xu, H., Y.Y. Zhang, J.W. Zhang, and D.F. Chen. 2007. Isolation and characterization of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii. International Immunopharmacology 7: 175–182.PubMedCrossRef
13.
go back to reference Fan, J., J.C. Marshall, M. Jimenez, P.N. Shek, J. Zagorski, and O.D. Rotstein. 1998. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. Journal of Immunology 161: 440–447. Fan, J., J.C. Marshall, M. Jimenez, P.N. Shek, J. Zagorski, and O.D. Rotstein. 1998. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. Journal of Immunology 161: 440–447.
14.
go back to reference Yoshinari, D., I. Takeyoshi, Y. Koibuchi, K. Matsumoto, Y. Kawashima, T. Koyama, S. Ohwada, and Y. Morishita. 2001. Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway. Critical Care Medicine 29: 628–634.PubMedCrossRef Yoshinari, D., I. Takeyoshi, Y. Koibuchi, K. Matsumoto, Y. Kawashima, T. Koyama, S. Ohwada, and Y. Morishita. 2001. Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway. Critical Care Medicine 29: 628–634.PubMedCrossRef
15.
go back to reference Betsuyaku, T., J.M. Shipley, Z. Liu, and R.M. Senior. 1999. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. American Journal of Respiratory Cell and Molecular Biology 20: 1303–1309.PubMed Betsuyaku, T., J.M. Shipley, Z. Liu, and R.M. Senior. 1999. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. American Journal of Respiratory Cell and Molecular Biology 20: 1303–1309.PubMed
16.
go back to reference Yoko, I., B. Tomoko, N. Katsura, N. Yasuyuki, and N. Masaharu. 2005. Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. Experimental Gerontology 40: 315–323.CrossRef Yoko, I., B. Tomoko, N. Katsura, N. Yasuyuki, and N. Masaharu. 2005. Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. Experimental Gerontology 40: 315–323.CrossRef
17.
go back to reference Nahum, A., A. Adina, M. Eliau, R. Ishay, D. Shlomit, and K. Tamar. 2009. Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries. Toxicology and Applied Pharmacology 241: 154–162.CrossRef Nahum, A., A. Adina, M. Eliau, R. Ishay, D. Shlomit, and K. Tamar. 2009. Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries. Toxicology and Applied Pharmacology 241: 154–162.CrossRef
18.
go back to reference Moore, F.A., and E.E. Moore. 1995. Evolving concepts in the pathogenesis of postinjury multiple organ failure. The Surgical Clinics of North America 75: 257–277.PubMed Moore, F.A., and E.E. Moore. 1995. Evolving concepts in the pathogenesis of postinjury multiple organ failure. The Surgical Clinics of North America 75: 257–277.PubMed
19.
go back to reference Zhang, H., and G.Y. Sun. 2005. LPS induces permeability injury in lung microvascular endothelium via AT1 receptor. Archives of Biochemistry and Biophysics 441: 75–83.PubMedCrossRef Zhang, H., and G.Y. Sun. 2005. LPS induces permeability injury in lung microvascular endothelium via AT1 receptor. Archives of Biochemistry and Biophysics 441: 75–83.PubMedCrossRef
20.
go back to reference Lang, J.D., and J.M. Hickman-Davis. 2005. One-hit, two-hit…is there really any benefit? Clinical and Experimental Immunology 141: 211–214.PubMedCrossRef Lang, J.D., and J.M. Hickman-Davis. 2005. One-hit, two-hit…is there really any benefit? Clinical and Experimental Immunology 141: 211–214.PubMedCrossRef
21.
go back to reference Rotstein, O.D. 2003. Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. The Journal of Trauma 54: 203–206.CrossRef Rotstein, O.D. 2003. Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. The Journal of Trauma 54: 203–206.CrossRef
22.
go back to reference Tamandl, D., M. Bahrami, B. Wessner, G. Weigel, M. Ploder, W. Furst, E. Roth, G. Boltz-Nitulescu, and A. Spittler. 2003. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock 20: 224–229.PubMedCrossRef Tamandl, D., M. Bahrami, B. Wessner, G. Weigel, M. Ploder, W. Furst, E. Roth, G. Boltz-Nitulescu, and A. Spittler. 2003. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock 20: 224–229.PubMedCrossRef
23.
go back to reference Rocco, P.R.M., D.P. Momesso, R.C. Figueira, H.C. Ferreira, R.A. Cadete, A. Legora-Machado, V.L.G. Koatz, L.M. Lima, E.J. Barreiro, and W.A. Zin. 2003. Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury. European Respiratory Journal 22: 20–27.PubMedCrossRef Rocco, P.R.M., D.P. Momesso, R.C. Figueira, H.C. Ferreira, R.A. Cadete, A. Legora-Machado, V.L.G. Koatz, L.M. Lima, E.J. Barreiro, and W.A. Zin. 2003. Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury. European Respiratory Journal 22: 20–27.PubMedCrossRef
24.
go back to reference Niwa, M., A. Hara, Y. Kanamori, D. Hatakeyama, M. Saio, T. Takami, H. Matsuno, O. Kozawa, and T. Uematsu. 2000. Nuclear factor-kappaB activates dual inhibition sites in the regulation of tumor necrosis factor-alpha-induced neutrophil apoptosis. European Journal of Pharmacology 407: 211–219.PubMedCrossRef Niwa, M., A. Hara, Y. Kanamori, D. Hatakeyama, M. Saio, T. Takami, H. Matsuno, O. Kozawa, and T. Uematsu. 2000. Nuclear factor-kappaB activates dual inhibition sites in the regulation of tumor necrosis factor-alpha-induced neutrophil apoptosis. European Journal of Pharmacology 407: 211–219.PubMedCrossRef
25.
go back to reference Michael, T.G., B. Karim, J.C. Mitchell, A.S. Lisa, C.W. Mary, L.S. Gregory, and P. Jean-Francois. 2007. Role of the alternative pathway in the early complement activation following major trauma. Shock 28: 29–34.CrossRef Michael, T.G., B. Karim, J.C. Mitchell, A.S. Lisa, C.W. Mary, L.S. Gregory, and P. Jean-Francois. 2007. Role of the alternative pathway in the early complement activation following major trauma. Shock 28: 29–34.CrossRef
26.
go back to reference Guo, R.F., and P.A. Ward. 2005. Role of C5a in inflammatory responses. Annual Review of Immunology 23: 821–852.PubMedCrossRef Guo, R.F., and P.A. Ward. 2005. Role of C5a in inflammatory responses. Annual Review of Immunology 23: 821–852.PubMedCrossRef
27.
go back to reference Drouin, S.M., J. Kildsgaard, J. Haviland, J. Zabner, H.P. Jia, P.B.J. McCray, B.F. Tack, and R.A. Wetsel. 2001. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. Journal of Immunology 166: 2025–2032.PubMed Drouin, S.M., J. Kildsgaard, J. Haviland, J. Zabner, H.P. Jia, P.B.J. McCray, B.F. Tack, and R.A. Wetsel. 2001. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. Journal of Immunology 166: 2025–2032.PubMed
28.
go back to reference Ward, P.A. 1996. Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury. The American Journal of Pathology 149: 1081–1086.PubMed Ward, P.A. 1996. Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury. The American Journal of Pathology 149: 1081–1086.PubMed
29.
go back to reference Gustavo, M.B., W.F. Charles, and R.M. Thomas. 2008. Animal models of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 295: 379–399.CrossRef Gustavo, M.B., W.F. Charles, and R.M. Thomas. 2008. Animal models of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 295: 379–399.CrossRef
Metadata
Title
Beneficial Effect of the Polysaccharides from Bupleurum smithii var. parvifolium on “Two-Hit” Acute Lung Injury in Rats
Authors
Xiao-Qin Cheng
Lu-Jin Song
Hong Li
Hongye Di
Yun-Yi Zhang
Dao-Feng Chen
Publication date
01-10-2012
Publisher
Springer US
Published in
Inflammation / Issue 5/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9489-7

Other articles of this Issue 5/2012

Inflammation 5/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.